Evidence for Hox-specified positional identities in adult vasculature
© Pruett et al; licensee BioMed Central Ltd. 2008
Received: 02 June 2008
Accepted: 30 September 2008
Published: 30 September 2008
The concept of specifying positional information in the adult cardiovascular system is largely unexplored. While the Hox transcriptional regulators have to be viewed as excellent candidates for assuming such a role, little is known about their presumptive cardiovascular control functions and in vivo expression patterns.
We demonstrate that conventional reporter gene analysis in transgenic mice is a useful approach for defining highly complex Hox expression patterns in the adult vascular network as exemplified by our lacZ reporter gene models for Hoxa3 and Hoxc11. These mice revealed expression in subsets of vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) located in distinct regions of the vasculature that roughly correspond to the embryonic expression domains of the two genes. These reporter gene patterns were validated as authentic indicators of endogenous gene expression by immunolabeling and PCR analysis. Furthermore, we show that persistent reporter gene expression in cultured cells derived from vessel explants facilitates in vitro characterization of phenotypic properties as exemplified by the differential response of Hoxc11-lacZ-positive versus-negative cells in migration assays and to serum.
The data support a conceptual model of Hox-specified positional identities in adult blood vessels, which is of likely relevance for understanding the mechanisms underlying regional physiological diversities in the cardiovascular system. The data also demonstrate that conventional Hox reporter gene mice are useful tools for visualizing complex Hox expression patterns in the vascular network that might be unattainable otherwise. Finally, these mice are a resource for the isolation and phenotypic characterization of specific subpopulations of vascular cells marked by distinct Hox expression profiles.
The Hox transcriptional regulators are known to play a critical role in establishing positional identities during embryonic patterning , whereas in postnatal and adult tissues, their functions are largely subject to speculation . This also pertains to the adult cardiovascular system, although Hox genes are considered prime candidates for determining phenotypic characteristics of vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) during vasculogenesis and vascular remodeling both under normal (e.g. wound healing, menstrual cycle) and pathologic conditions (e.g. cancer-related angiogenesis, atherosclerosis) . A prerequisite for defining these roles and underlying molecular mechanisms is information about Hox expression patterns in adult vasculature in vivo, which is currently scarcely available.
Considering the documented expression of various members of this gene family in ECs and VSMCs , the near-void of data concerning phenotypic changes in the cardiovascular system of the numerous Hox gene-targeted and transgenic mice is surprising. A notable exception is the Hoxa3 gene-targeted mice, which exhibit a range of cardiovascular defects [4–6], although a definition of the molecular mechanisms underlying these defects was essentially precluded due to lack of information about the cardiovascular Hoxa3 expression pattern, both in the embryo and the adult. Perhaps of equal relevance is that in the fruit fly Drosophila melanogaster the Hox gene abdA is required for specifying cell identity in a posterior section of the Drosophila dorsal vessel, which is functionally equivalent to the vertebrate heart .
Since these seminal observations with Hoxa3 and abdA in mice and flies, respectively, a series of studies has shown differential expression of Hox genes in ECs of different origin with respect to species and vessel type. For example, 8 of the 10 human HOXB genes were found expressed in cultured umbilical vein ECs and this expression could be modulated by vascular signaling molecules including tissue plasminogen activator (TPA), and vascular endothelial growth factor (VEGF) . Most of the studies involving endothelial Hox expression suggest a role in the regulation of angiogenesis, i.e. the formation of new blood vessels and microvasculature associated either with normal developmental and physiological processes such as mammary gland development and wound healing or with pathological conditions such as tumorigenesis [8–16].
Evidence for Hox expression in VSMCs was initially provided by showing Hoxa2 expression in VSMCs of embryonic vessels leading from the heart, in embryonic cardiomyocytes, and in adult aortic VSMCs ; this was facilitated by the isolation of a Hoxa2-specific cDNA from a rat aorta-derived cDNA library. Additional VSMC-specific Hox cDNAs (HOXA5, HOXA11, HOXB1, HOXB7, and HOXC9) were isolated from fetal and adult human VSMC cDNA libraries by using degenerate primers corresponding to a highly conserved subregion of the homeobox for screening . Although providing more direct evidence for in vivo expression of any of the corresponding genes in fetal or adult aorta remained elusive in that study, the potential relevance of these data was underscored in a separate study showing scattered expression of HOXB7 in media and neointima adjacent to calcification in human atherosclerotic plaques . To assess whether this might reflect a role in directing immature cells towards either osteoblastic or VSMC differentiation, HOXB7 was overexpressed in multipotent C3H10T1/2 cells that are capable of differentiating into VSMCs, as well as osteogenic and chondrogenic lineages. The results showed 3.5-fold increase in proliferation and induction of VSMC-like morphology, thus suggesting a role for HOXB7 in the expansion of immature cell populations or dedifferentiation of mature cells . Of relevance in this context is the apparent VSMC phenotype-dependent expression of HOXB7 and HOXC9 as evidenced by preferential expression in cultured fetal versus adult VSMCs, a result that might indicate a role for Hox genes in the control of VSMC-diversity .
Although the activity patterns in different cardiovascular lineages suggest potentially significant roles for Hox genes in cardiovascular patterning and remodeling, nearly none of these have been defined in vivo. Perhaps one of the most confounding factors is an inherent difficulty in defining gene expression patterns in a structurally and physiologically diverse organ system branched throughout the entire body. To overcome this obstacle, we used lacZ reporter gene analysis in transgenic mice to obtain an approximate global view of the postnatal and adult vascular expression patterns of two Hox genes, Hoxa3 and Hoxc11. The data indicate distinct regionally restricted zones of expression that roughly correspond to the disparate embryonic expression domains of the two genes. These results support a role for Hox genes in specifying and maintaining positional identities of VSMCs and ECs in the adult vasculature.
Materials and methods
Cloning of Hoxa3-lacZ
A segment of genomic DNA of 11,473 base pairs (bp) located directly upstream of the Hoxa3 translational start codon was fused to E.coli lacZ derived from plasmid pCH110 (Amersham Pharmacia). The Hoxa3 fragment was derived from mouse genomic BAC clone RP24-353A14 (Children's Research Institute, Oakland, CA) and extended from the NruI restriction half-site located just 2 bp upstream of the Hoxa3 translational start codon  to the BamHI site at position -11,473 relative to the translational start. Hoxa3-lacZ was cloned in a pBluescript (Promega) -derived vector termed pSafyre  and released by Spe1 and Not1 restriction enzymes for the preparation of transgenic mice. Transgenic lacZ reporter studies showed previously that sequences located upstream of the Hoxa3 coding region contain both transcriptional promoter and enhancer functions capable of reconstructing the main aspects of endogenous Hoxa3 expression in E8.5-E9.5 mouse embryos (Hoxa3 reporter gene analysis: ; endogenous Hoxa3 expression: [22–24]).
A Hoxc11-lacZ transgenic line carrying the LZc11-S construct was reported previously . LZc11-S contained a 10 kb genomic fragment including the Hoxc11 transcription unit in addition to 2 kb and 5 kb of Hoxc11 upstream and downstream flanking sequences, respectively, as well as E.coli lacZ fused in frame to first exon coding sequences ; LZc11-S consistently reproduced endogenous Hoxc11 expression pattern in E11.5 – E13.5 embryos (n = 3 founders, including 2 transgenic lines). One of the LZc11-S lines has been designated TG(Hoxc11/lacZ)62D9Awg  and kept on FVB/NTac strain background. Mice from this line were used for lacZ expression analysis in blood vessels at postnatal and adult stages up to 1 year of age.
Hoxa3-lacZ mice were made according to standard transgenic procedures using single-cell FVB/NTac embryos. Transient transgenic mice (n = 6) and mice from one transgenic line designated TG(Hoxa3-lacZ)184H3Awg  were analyzed for reporter gene expression patterns at embryonic stage E14.5 (2 transient) and at 11 days post natum (p.n.) (2 transient), as well as at adult age of ≥ 6 weeks (line TG(Hoxa3-lacZ)184H3Awg, plus 2 transient transgenic mice). Patterns observed at E14.5 were consistent with the endogenous Hoxa3 expression patterns previously reported, albeit at earlier stages of embryonic development [22–24]. Among the postnatal and adult transient transgenic mice and the F1 mice of the TG(Hoxa3-lacZ)184H3Awg line, the vascular expression patterns observed at 11 days p.n. and at ≥ 6 weeks were consistent.
X-Gal staining of lacZreporter mouse tissue
Vascular tissues were fixed in a solution containing 0.2% glutaraldehyde, 2% paraformaldehyde, 2 mM MgCl2 in PBS at room temperature for periods ranging from 20 minutes to 1 hr depending on tissue. After rinsing for several hours in detergent solution containing 2 mM MCl2, 0.02% Nonidet P-40, 0.0001% Na-deoxycholate in PBS, the tissues were stained overnight at 32°C in a solution containing 20 mM Tris-HCl (pH 7.3), 2 mM MgCl2, 0.02% Nonidet P-40, 0.0001% Na-deoxycholate, 20 mM potassium-ferrocyanide, 20 mM potassium-ferricyanide, and 0.625 mg/ml X-Gal in PBS. After rinsing in PBS, stained tissues were fixed in 4% paraformaldehyde. For the preparation of frozen sections, stained tissues were infiltrated with 30% sucrose/PBS overnight at 4°C prior to embedding in OCT compound; tissues were cryosectioned and imaged using differential interference contrast (DIC) imaging.
Reverse transcriptase (RT) – PCR
Under isoflurane anesthesia by inhalation, mouse tissues were prepared by transcardial perfusion with diluted (80%) RNAlater (Ambion, Austin, TX) to stabilize vascular tissue prior to excision followed by overnight incubation in undiluted RNAlater at 4°C. Vascular tissues were homogenized, and RNA was isolated with TRIzol Reagent (Invitrogen, Carlsbad, CA) according to manufacturers instructions and subsequently treated with RQ1 RNAse-free DNase (Promega, Madison WI). First-strand cDNA was prepared from total RNA using Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA). Gene-specific cDNA fragments were amplified with AmpliTaq Gold DNA Polymerase (Applied Biosystems, Foster City, CA) using the following primers: Hoxa3 (218 bp), F-GGGCACCGATGGCGTTGAGT and R-GCTGTGGTGGGGGCTGTGGA; Hoxc11 (311 bp), F-CCGGAGGAGGCAGGAGAAGA and R-CCGCCGCATAACAAGACGA. Gapdh primers were used for positive control reaction.
Immunofluorescence (IF) labeling/Immunohistochemistry (IHC)
Under isoflurane anesthesia by inhalation, 8 week old normal FVB and TG(Hoxa3-lacZ)184H3Awg mouse tissues were prepared by transcardial perfusion with 0.1 M PIPES-buffered (pH 7.0) 2% paraformaldehyde followed by overnight immersion of excised tissues in PIPES-buffered 0.2% paraformaldehyde at 4°C. Carotid and dorsal aorta tissues were subsequently processed for cryosectioning (7 μm). For IF, rabbit anti-mouse primary antibodies for Hoxa3 (Santa Cruz Biotechnology, Santa Cruz, CA) and smooth muscle-specific Cy3-conjugated anti-Acta2 (Smooth muscle alpha actin [SMαA] Sigma, St. Louis, MO) were applied to carotid cross-sections at 10 μg/ml at room temperature for 2 hours following antigen retrieval with 10 mM Sodium Citrate (pH 6.0) buffer and brief microwave heating. For immunolocalization, fluorochrome-conjugated (Cy3 or Cy5) donkey anti-rabbit secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were used. Cell nuclei were stained with Hoechst 33342. Fluorescence imaging at 400× was conducted using a Leica DMRB HC microscope, supported by a digital imaging workstation that includes a real time color digital camera (SPOT-RT) and a Gateway1400 PC.
For immunocytofluorescence (ICF), smooth muscle cells from dissociated vessel (see below) were immunolabeled with primary antibodies specific for either Hoxc11, β-gal, or Transgelin (SM22a; Abcam, Cambridge, MA) and detected with appropriate fluorochrome secondary antibodies followed by Hoechst 33342 nuclear labeling as described above. ICF/X-Gal double-labeling was accomplished by labeling the fixed cells with X-Gal prior to incubation with Cy3-conjugated anti-Acta2 antibodies and Hoechst 33342.
For IHC, rabbit anti-mouse primary antibodies for Hoxa3 were applied to dorsal aorta cross-sections at 10 μg/ml at room temperature for 2 hours following antigen retrieval with 10 mM Sodium Citrate (pH 6.0) buffer and brief microwave heating. Immunolocalization was detected with Vectastain ABC Kit utilizing peroxidase-conjugated anti-rabbit IgG antibodies and color detection with DAB, perioxidase substrate kit (Vector Labs, Burlingame, CA) according to manufacturers instructions. Micrographs of DAB-labeled sections were taken with differential interference contrast (DIC) imaging at 630×.
Vessel explant cultures – in vitroassays
Small segments (2 mm length) of the lateral marginal vein and the femoral artery (mid-femoral region) of 6 weeks old Hoxc11-lacZ mice were dissected and placed into collagen-coated culture chambers. Explants were cultured in M199 medium supplemented with 20% FBS and pen-strep-glutamine. Outgrowing cells could be observed initially after ≈ 4 days, and cell density increased with prolonged culture.
To assess possible differential migration rates of transgene (Hoxc11-lacZ) expressing versus non-expressing cells, VSMCs from primary cultures were collected subsequent to the 5th passage and plated in multi-well (4 wells) chambered slides at a concentration of approximately 500 cells/cm2 in M199 media supplemented with 20% fetal calf serum (FCS). Cultures were allowed to grow to near confluence then "scratched" with a 200 μL pipette tip producing a 0.8 mm wound traversing the length of each chamber (2 cm). Under DIC imaging the wounded area was defined and marked for subsequent orientation at 100×. Cultures were allowed to grow for 24 hrs prior to processing for X-Gal labeling as described above with minor alterations: cells were fixed for 8 min prior to labeling. Using DIC imaging randomly selected fields were chosen from scratched areas of the four experimental wells and photographed at 100×; randomly selected fields from "normal" un-scratched areas were likewise imaged and photographed and used as negative controls. β-gal-positive (blue) and -negative cells of the experimental and control groups were scored and expressed as proportions of total number of cells and differences expressed as -fold change between groups. Data were expressed as mean ± standard deviation, and statistical significance (defined as P < 0.05) was determined using Student's t-test. For ICF experiments, cells were dissociated by enzymatic digestion (M199 media supplemented with 0.3 mg/ml elastase type III [Sigma, St. Louis MO], 1.8 mg/ml collagenase type I [Sigma, St. Louis MO] and 0.44 mg/ml soybean trypsin inhibitor [Sigma, St. Louis MO]) at 37°C for 1 hr prior to plating under the conditions as described above.
Hoxc11 Antibody Production
Custom-made, affinity-purified, chicken-anti-mouse Hoxc11 antibodies were synthesized (Sigma Genosys, St. Louis MO) against an epitope of the Hoxc11 protein with the peptide sequence PPSTVTEILMKNEGS that comprises amino acid residues 106 – 120 of the variable region of the Hoxc11 protein; the human equivalent of this epitope was previously used successfully for raising HOXC11 antibodies . Please note that the antibodies directed against this peptide are unable to recognize the Hoxc11-βgal fusion protein produced by the TG(Hoxc11/lacZ)62D9Awg mice as the lacZ coding region displaces Hoxc11 amino acids 96 – 304 in the transgene protein product . Keyhole limpet hemocyanin (KLH) was selected as the peptide carrier protein and conjugation was achieved through attachment to the thiol-group of an additional cysteine residue placed at the N-terminus of the peptide sequence. The specificity of the affinity-purified antisera was determined by ELISA, as well as immunolabeling experiments with sagittal and cross sections of E12.5 mouse embryos that yielded detection patterns very similar to the familiar Hoxc11 RNA expression patterns ([28, 29]; data not shown).
Distinct Hoxc11- and Hoxa3-lacZexpression patterns in adult blood vessels
In addition to expression in blood vessels, we observed strong and specific Hoxc11-lacZ activity in kidney, ureter, urinary bladder, and uterus (data not shown). This activity in both the male and female urogenital system is consistent with previously reported endogenous Hoxc11 expression in the metanephric mesenchyme during mid-gestation, and in cortical regions of the developing kidney during later development , as well as HOXC11 expression in human uterine endometrium . Furthermore, we also observed diffuse β-gal activity in hindlimb cartilage and skeletal muscle of postnatal and adult mice (Fig. 1B, C, E); although this activity apparently became gradually weaker and increasingly restricted to distal limb regions with age, it was still clearly detectable in 1 year old mice (Fig. 1G). This may indicate that endogenous Hoxc11 expression in skeletal muscle, first observed in embryonic myotomes and developing muscle during fetal development , persists in adulthood.
Validation of Hoxc11 and Hoxa3reporter gene expression patterns
To obtain supporting evidence for regionally restricted expression of endogenous Hoxa3 and Hoxc11 within the vascular network, we isolated RNA from the aortic arch, the descending thoracic aorta, and the distal femoral artery (the distal femoral artery segment used was as defined above) for RT-PCR analysis. In agreement with the Hoxa3- and Hoxc11-lacZ reporter gene analysis, the data indicate Hoxa3 expression in the aortic arch and the descending thoracic aorta but not in the distal femoral artery, whereas Hoxc11 expression is detectable exclusively in the latter (Fig. 4B).
Hoxc11-lacZ expression ex vivo
VSMCs are capable of exhibiting a wide range of different phenotypes in response to changes in local environmental cues, a phenomenon known as phenotypic modulation or phenotype switching [31, 32]. The morphologically and functionally distinct synthetic and contractile VSMCs are considered to mark the boundaries at the opposite ends of a spectrum within which VSMCs can modulate their phenotypic properties . The decreased Hoxc11-lacZ expression in migrating cells is consistent with the lower level of reporter gene activity in response to serum – in both cases the phenotypic equilibrium is shifted towards a proliferative and synthetic phenotype . Accordingly, these data suggest preferential Hoxc11 activity in contractile VSMCs of spindle-like morphology.
In keeping with the positional identity model, recent global gene expression profiling revealed that similar to fibroblasts, ECs and SMCs exhibit considerable diversity depending on function and anatomic site [38, 39]. Within the cardiovascular system, this is likely to reflect diverse physiological requirements, including regional variations in vessel tone, blood flow, blood pressure, oxygen content, nutrient content, etc., and Hox genes are considered excellent candidates for orchestrating the corresponding regional gene expression profiles [3, 38, 39]. Data demonstrating that genes encoding SMC-restricted proteins are direct targets of Hox transcription factors  are consistent with this model. Furthermore, several Hox genes (including Hoxa3) have been implicated in controlling the conversion of ECs to the angiogenic phenotype , which is of great relevance for tumor-angiogenesis, as well as for neo-vascularization during wound healing and other normal adult physiological activities. Likewise, phenotype switching of VSMCs is known to be associated with a wide range of diseases of the cardiovascular system including atherosclerosis, stroke, high blood pressure, aneurisms, etc. . Our data showing Hoxc11 expression to be restricted to a subset of VSMCs derived from the same vessel and anatomic site as VSMCs not expressing Hoxc11 may indicate that Hox expression profiles are associated with distinct VSMC phenotypes. This proposition is further underscored by the preliminary results from our functional assays suggesting a role for Hoxc11 in defining phenotypic properties of VSMCs. Taken together, elucidating the role of Hox genes in adult blood vessels is likely to be critically important for understanding vascular disease mechanisms.
Our results support a conceptual model of Hox-specified positional identities in adult blood vessels, which is of likely relevance for understanding the mechanisms underlying regional physiological diversities in the cardiovascular system. The data also demonstrate that conventional Hox reporter gene mice are useful tools for visualizing complex Hox expression patterns in the vascular network that might be unattainable otherwise. Importantly, these mice are a valuable resource for the isolation and phenotypic characterization of specific subpopulations of vascular cells marked by distinct Hox expression profiles.
We thank Dr. R. Markwald for advice and critical reading of the manuscript. This work was supported by NIAMS grants AR047204 and AR 053639 to A.A., and NHLBI training grant HL07260 to N.D.P. Transgenic mice were created in a facility constructed with support from NIH grant C06 RR015455 of the Extramural Research Facilities Program of the National Center for Research Resources.
- McGinnis W, Krumlauf R: Homeobox genes and axial patterning. Cell. 1992, 68: 283-302. 10.1016/0092-8674(92)90471-N.View ArticlePubMedGoogle Scholar
- Morgan R: Hox genes: a continuation of embryonic patterning?. Trends Genet. 2006, 22: 67-69. 10.1016/j.tig.2005.11.004.View ArticlePubMedGoogle Scholar
- Gorski DH, Walsh K: Control of vascular cell differentiation by homeobox transcription factors. Trends Cardiovasc Med. 2003, 13: 213-220. 10.1016/S1050-1738(03)00081-1.View ArticlePubMedGoogle Scholar
- Chisaka O, Capecchi MR: Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature. 1991, 350: 473-479. 10.1038/350473a0.View ArticlePubMedGoogle Scholar
- Kameda Y, Nishimaki T, Takeichi M, Chisaka O: Homeobox gene hoxa3 is essential for the formation of the carotid body in the mouse embryos. Dev Biol. 2002, 247: 197-209. 10.1006/dbio.2002.0689.View ArticlePubMedGoogle Scholar
- Kameda Y, Watari-Goshima N, Nishimaki T, Chisaka O: Disruption of the Hoxa3 homeobox gene results in anomalies of the carotid artery system and the arterial baroreceptors. Cell Tissue Res. 2003, 311: 343-352.PubMedGoogle Scholar
- Lovato TL, Nguyen TP, Molina MR, Cripps RM: The Hox gene abdominal-A specifies heart cell fate in the Drosophila dorsal vessel. Development. 2002, 129: 5019-5027.PubMedGoogle Scholar
- Belotti D, Clausse N, Flagiello D, Alami Y, Daukandt M, Deroanne C, Malfoy B, Boncinelli E, Faiella A, Castronovo V: Expression and modulation of homeobox genes from cluster B in endothelial cells. Lab Invest. 1998, 78: 1291-1299.PubMedGoogle Scholar
- Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA: Induction of the angiogenic phenotype by Hox D3. J Cell Biol. 1997, 139: 257-264. 10.1083/jcb.139.1.257.View ArticlePubMed CentralPubMedGoogle Scholar
- Boudreau NJ, Varner JA: The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem. 2004, 279: 4862-4868. 10.1074/jbc.M305190200.View ArticlePubMedGoogle Scholar
- Bruhl T, Urbich C, Aicher D, Acker-Palmer A, Zeiher AM, Dimmeler S: Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res. 2004, 94: 743-751. 10.1161/01.RES.0000120861.27064.09.View ArticlePubMedGoogle Scholar
- Myers C, Charboneau A, Boudreau N: Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol. 2000, 148: 343-351. 10.1083/jcb.148.2.343.View ArticlePubMed CentralPubMedGoogle Scholar
- Myers C, Charboneau A, Cheung I, Hanks D, Boudreau N: Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol. 2002, 161: 2099-2109.View ArticlePubMed CentralPubMedGoogle Scholar
- Rhoads K, Arderiu G, Charboneau A, Hansen SL, Hoffman W, Boudreau N: A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol. 2005, 3: 240-252. 10.1089/lrb.2005.3.240.View ArticlePubMedGoogle Scholar
- Soncin F, Fafeur V, Vandenbunder B: [Transcription factors and angiogenesis]. Pathol Biol (Paris). 1999, 47: 358-363.Google Scholar
- Uyeno LA, Newman-Keagle JA, Cheung I, Hunt TK, Young DM, Boudreau N: Hox D3 expression in normal and impaired wound healing. J Surg Res. 2001, 100: 46-56. 10.1006/jsre.2001.6174.View ArticlePubMedGoogle Scholar
- Patel CV, Gorski DH, LePage DF, Lincecum J, Walsh K: Molecular cloning of a homeobox transcription factor from adult aortic smooth muscle. J Biol Chem. 1992, 267: 26085-26090.PubMedGoogle Scholar
- Miano JM, Firulli AB, Olson EN, Hara P, Giachelli CM, Schwartz SM: Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells. Proc Natl Acad Sci USA. 1996, 93: 900-905. 10.1073/pnas.93.2.900.View ArticlePubMed CentralPubMedGoogle Scholar
- Bostrom K, Tintut Y, Kao SC, Stanford WP, Demer LL: HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells. J Cell Biochem. 2000, 78: 210-221. 10.1002/(SICI)1097-4644(20000801)78:2<210::AID-JCB4>3.0.CO;2-Z.View ArticlePubMedGoogle Scholar
- Vega Mouse. [http://vega.sanger.ac.uk/Mus_musculus]
- Bieberich CJ, Utset MF, Awgulewitsch A, Ruddle FH: Evidence for positive and negative regulation of the Hox-3.1 gene. Proc Natl Acad Sci USA. 1990, 87: 8462-8466. 10.1073/pnas.87.21.8462.View ArticlePubMed CentralPubMedGoogle Scholar
- Manzanares M, Cordes S, Ariza-McNaughton L, Sadl V, Maruthainar K, Barsh G, Krumlauf R: Conserved and distinct roles of kreisler in regulation of the paralogous Hoxa3 and Hoxb3 genes. Development. 1999, 126: 759-769.PubMedGoogle Scholar
- Gaunt SJ: Homoeobox gene Hox-1.5 expression in mouse embryos: earliest detection by in situ hybridization is during gastrulation. Development. 1987, 101: 51-60.PubMedGoogle Scholar
- Manley NR, Capecchi MR: The role of Hoxa-3 in mouse thymus and thyroid development. Development. 1995, 121: 1989-2003.PubMedGoogle Scholar
- Papenbrock T, Visconti RP, Awgulewitsch A: Loss of fibula in mice overexpressing Hoxc11. Mech Dev. 2000, 92: 113-123. 10.1016/S0925-4773(99)00344-5.View ArticlePubMedGoogle Scholar
- International Mouse Strain Resource (IMSR). [http://www.informatics.jax.org/imsr]
- Dasen JS, Tice BC, Brenner-Morton S, Jessell TM: A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell. 2005, 123: 477-491. 10.1016/j.cell.2005.09.009.View ArticlePubMedGoogle Scholar
- Hostikka SL, Capecchi MR: The mouse Hoxc11 gene: genomic structure and expression pattern. Mech Dev. 1998, 70: 133-145. 10.1016/S0925-4773(97)00182-2.View ArticlePubMedGoogle Scholar
- Peterson RL, Papenbrock T, Davda MM, Awgulewitsch A: The murine Hoxc cluster contains five neighboring AbdB-related Hox genes that show unique spatially coordinated expression in posterior embryonic subregions. Mech Dev. 1994, 47: 253-260. 10.1016/0925-4773(94)90043-4.View ArticlePubMedGoogle Scholar
- Akbas GE, Taylor HS: HOXC and HOXD gene expression in human endometrium: lack of redundancy with HOXA paralogs. Biol Reprod. 2004, 70: 39-45. 10.1095/biolreprod.102.014969.View ArticlePubMedGoogle Scholar
- Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995, 75: 487-517.PubMedGoogle Scholar
- Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004, 84: 767-801. 10.1152/physrev.00041.2003.View ArticlePubMedGoogle Scholar
- Rensen SS, Doevendans PA, van Eys GJ: Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 2007, 15: 100-108.View ArticlePubMed CentralPubMedGoogle Scholar
- Wolpert L: One hundred years of positional information. Trends Genet. 1996, 12: 359-364. 10.1016/S0168-9525(96)80019-9.View ArticlePubMedGoogle Scholar
- Chang HY, Chi JT, Dudoit S, Bondre C, Rijn van de M, Botstein D, Brown PO: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA. 2002, 99: 12877-12882. 10.1073/pnas.162488599.View ArticlePubMed CentralPubMedGoogle Scholar
- Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY: Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet. 2006, 2: e119-10.1371/journal.pgen.0020119.View ArticlePubMed CentralPubMedGoogle Scholar
- Kessel M, Gruss P: Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell. 1991, 67: 89-104. 10.1016/0092-8674(91)90574-I.View ArticlePubMedGoogle Scholar
- Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, Rijn van de M, Botstein D, Brown PO: Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA. 2003, 100: 10623-10628. 10.1073/pnas.1434429100.View ArticlePubMed CentralPubMedGoogle Scholar
- Chi JT, Rodriguez EH, Wang Z, Nuyten DS, Mukherjee S, Rijn van de M, Vijver van de MJ, Hastie T, Brown PO: Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers. PLoS Genet. 2007, 3: 1770-1784. 10.1371/journal.pgen.0030164.View ArticlePubMedGoogle Scholar
- El-Mounayri O, Triplett JW, Yates CW, Herring BP: Regulation of smooth muscle-specific gene expression by homeodomain proteins, Hoxa10 and Hoxb8. J Biol Chem. 2005, 280: 25854-25863. 10.1074/jbc.M501044200.View ArticlePubMedGoogle Scholar
- Mace KA, Hansen SL, Myers C, Young DM, Boudreau N: HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci. 2005, 118: 2567-2577. 10.1242/jcs.02399.View ArticlePubMedGoogle Scholar